Tsumura & Co ( (JP:4540) ) has provided an announcement.
Tsumura & Co. has finalized the offer price for a secondary offering of its common shares, aiming to raise over 10 billion yen. This move is part of a strategic effort to strengthen its financial position and expand its market reach, with a significant portion of shares being sold to foreign investors in Europe and Asia.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, primarily focusing on the production and sale of Kampo medicines, which are traditional Japanese herbal medicines. The company is listed on the TSE Prime Market and targets both domestic and international markets, excluding the US and Canada.
YTD Price Performance: -4.67%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.18B
For a thorough assessment of 4540 stock, go to TipRanks’ Stock Analysis page.